Business
XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration
XtalPi, a leading life sciences and new materials R&D platform powered by quantum physics, AI and robotics, today announced its acquisition of Liverpool ChiroChem (LCC), a pioneer in automated chiral chemistry technologies. This strategic merger will enhance XtalPi's ability to explore and synthesize novel chemical space with speed and precision, accelerating innovation for pharmaceutical, materials, agricultural, and specialty chemical applications. The acquisition underscores XtalPi's commitme
About this update from Xtalpi Holdings Limited
[{"type":"text","content":"CAMBRIDGE, Mass. and LIVERPOOL, United Kingdom, June 13, 2025 /PRNewswire/ -- XtalPi, a leading life sciences and new materials R&D platform powered by quantum physics, AI and robotics, today announced its acquisition of Liverpool ChiroChem (LCC), a pioneer in automated chiral chemistry technologies. This strategic merger will enhance XtalPi's ability to explore and synthesize novel chemical space with speed and precision, accelerating innovation for pharmaceutical, materials, agricultural, and specialty chemical applications. The acquisition underscores XtalPi's commitment to advancing the frontiers of chemical discovery and delivering transformative solutions to partners worldwide.","length":704,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/XtalPi Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/XtalPi Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":213,"url":"https://media.zenfs.com/en/prnewswire.com/096d1c8437cb84e2a88b2cfea6eea574"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kulhPIgmoSeVNZI4ag87kQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM3NTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/096d1c8437cb84e2a88b2cfea6eea574","width":400,"height":213}},"href":"https://mma.prnewswire.com/media/2374018/XtalPi_EN_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Founded in 2014 at the University of Liverpool, UK, LCC has established itself as a global leader in high-throughput novel chiral molecule design and synthesis, serving multinational pharmaceutical companies and specialist biotech firms across the US, Europe, and Asia. Its PACE (Parallel Automated Chiral Engine) technology combines AI software with automation, delivering a vast collection of unique, stereodefined, and diverse chiral building blocks, alongside a proprietary billion-scale virtual chiral library.","length":515,"tagName":"p"},{"type":"text","content":"XtalPi's R&D platform integrates quantum physics and AI predictions with large-scale automated chemistry experiments to generate, screen, and validate novel compounds with tailored physiochemical properties and molecular functionalities. By incorporating LCC's world-leading chiral chemistry expertise into its intelligent autonomous chemistry platform, XtalPi will further broaden its accessible an...